Is there a relationship between aspirin and bowel cancer? – 04/29/2023

Who among us has not heard of a drug called aspirin? Do you know when this product was first marketed? 1899! Perhaps we can say that aspirin was a part of everyone’s childhood and practically accompanied the development and transformations of the world in the last century.

When aspirin relates to diseases in general, we immediately think of using this product to treat cardiovascular problems, such as heart attacks and Leak brain. In addition to treatment, it was very common to use aspirin as a preventive measure for the same cardiovascular problems. Finally, the role of aspirin, whether as a preventive or therapeutic measure, is part of the history of medicine and the life histories of many people.

Some research in recent years has shown that aspirin use can have another very important protective effect: protection against bowel cancer in both men and women. Bowel cancer is directly related to the quality of our food, and in recent months many well-known people, such as former player Pele and singers Simone and Britta Gil, have suffered or are battling this disease. The habit of eating fatty foods and sweets in large quantities can be decisive in the development of this type of cancer.

The connection between aspirin and its protective role against bowel cancer appears to be related to the anti-inflammatory effect of this drug. Aspirin performs some beneficial functions in our bodies such as relieving pain, reducing inflammation, preventing blood clots, and stimulating blood flow. These functions are made possible by inhibiting the production of certain proteins that cause inflammation in our bodies. Most studies show this coincidence or association that people using low-dose aspirin can reduce bowel cancer rates by 20-40%.

Low doses of aspirin studied may include a daily intake of 81 to 325 mg. Because this dose range is relatively wide, some of the more definitive studies have been done to compare the protective effects of aspirin in two groups — those taking 81 to 160 mg per day versus those taking 300 to 325 mg per day. The conclusion was interesting, as it was clear that there was no difference between these two doses, particularly with regard to the prevention of bowel cancer.

This conclusion has a positive side and is very beneficial for those people who suffer from some kind of intolerance to the daily use of aspirin. It is always necessary to point out that aspirin can lead to some side effects, such as bruising (purple spots on the skin), bleeding stools and stomach pain.

Low doses of aspirin, in addition to its potential to prevent the development of bowel cancer, can act against metastasis, that is, the spread of cancer to sites near or far from the initial site of cancer. Bowel cancer has a reasonable probability of metastasis, and it can spread to organs such as the lungs and liver.

Science has moved toward identifying the people or personality traits of people who would best respond to preventive use of aspirin, with particular consideration in bowel cancer.

In any case, the evidence points to a much broader protective role for aspirin than one might imagine, and it is not limited to the realm of cardiovascular disease. In combination with a diet high in fiber and restriction of fats and sugars, low-dose aspirin consumption can add anti-inflammatory benefits, which are needed to prevent the development of bowel cancer and, ultimately, help control the potential for established metastasis. Bowel cancer.